178550-55-5

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 174582-83-3 (4S,5S)-4-benzyloxymethyl-5-<(1R)-1-hydroxy-2-propen-1-yl>oxazolidin-2-one 
• 178738-22-2 (3aR,4S,5aR,8R,9aS,9bS)-4-Methoxy-8-phenyl-hexahydro-1,5,7,9-tetraoxa-3-aza-cyclopenta[a]naphthalen-2-one 
• 174582-79-7 methyl 4,6-O-benzylidene-2-deoxy-2-(methoxycarbonylamino)-α-D-allopyranoside 
• 174582-80-0 methyl 2-amino-4-O-benzoyl-6-bromo-2,3-N,O-carbonyl-2,6-dideoxy-α-D-allopyranoside 
• 174582-82-2 (4S,5S)-5-<(1R)-1-benzoyloxy-2-propen-1-yl>-4-hydroxymethyloxazolidin-2-one 
• 99679-75-1 Methyl-4,6-O-benzyliden-2-desoxy-2-<(methoxycarbonyl)amino>-α-D-ribo-hexopyranosid-3-ulose 

Relevant academic research and scientific papers

Synthesis of D-erythro-sphingosine from D-glucosamine

D-erythro-Sphingosine (1) was synthesized from D-glucosamine (2) as a chiral pool through stereoinversion of the C(3)-hydroxyl group via an oxidation-reduction sequence, transformation to the erythro-amino-alcohol chiron (9) protected as the oxazolidinone, and elongation of the side chain at the C(6)-position of the derived chloride (12).